MedicarePartD.guide

A non-government resource built from CMS public data

Long-acting (basal) insulin on every 2026 New York Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in New York cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Long-acting (basal) insulin by 2026 New York Part D plan
DrugHealthSpring Assurance Rx$35.70/moS5617-013Wellcare Value Script$42.40/moS4802-138Wellcare Classic$45.70/moS4802-077HealthSpring Extra Rx$91.60/moS5617-353AARP Medicare Rx Saver from UHC$105.80/moS5921-379SilverScript Choice$116.00/moS5601-006Humana Basic Rx Plan$140.90/moS5884-216Humana Value Rx Plan$158.90/moS5884-218AARP Medicare Rx Preferred from UHC$163.70/moS5921-382Humana Premier Rx Plan$173.60/moS5884-217
Lantusinsulin glargineTier 325%Tier 325%Tier 325%Tier 317%Tier 317%Tier 318%Tier 325%Tier 317%Tier 315%Tier 3$45.00
insulin glargineunbranded LantusNot coveredTier 325%Tier 325%Not coveredTier 317%Not coveredNot coveredNot coveredTier 315%Not covered
Basaglarinsulin glargineNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Semgleeinsulin glargine-yfgnNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Rezvoglarinsulin glargine-aglrNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Toujeoinsulin glargine, U-300Tier 325%Not coveredNot coveredTier 317%Tier 317%Not coveredTier 325%Tier 317%Tier 315%Tier 3$45.00
Tresibainsulin degludecNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 3$45.00

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.